ADRA2B Antikörper
Kurzübersicht für ADRA2B Antikörper (ABIN7672627)
Target
Alle ADRA2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- ADRA2B-Specific antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- adrenergic, alpha-2B-, receptor
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:200-1:1000, IHC: 1:50-1:500
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Haltbarkeit
- 12 months
-
-
- ADRA2B (Adrenergic, alpha-2B-, Receptor (ADRA2B))
-
Andere Bezeichnung
- ADRA2B
-
Hintergrund
-
Synonyms: Alpha-2B adrenergic receptor|Alpha-2 adrenergic receptor subtype C2|Alpha-2B adrenoreceptor (Alpha-2B adrenoceptor, Alpha-2BAR)|ADRA2B|ADRA2L1|ADRA2RL1
Background: ADRA2B, also named as ADRA2L1 and ADRA2RL1, belongs to the G-protein coupled receptor 1 family. ADRA2B mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The antibody is specific to ADRA2B.
-
Molekulargewicht
- 50 kDa
-
Gen-ID
- 151
-
UniProt
- P18089
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Target
-